Showing results (1-10 of 2,639) with videos related to
Sort By:
Pageof 264
Journal of Clinical Immunology|March 1, 1994
Bioavailability of gamma-globulin after subcutaneous infusions in patients with common variable immunodeficiencyJ Waniewski, A Gardulf, L HammarströmLancet (London, England)|July 20, 1991
Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusionA Gardulf, L Hammarström, C I SmithClinical and Experimental Immunology|March 18, 2008
Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficienciesR Gustafson, A Gardulf, S Hansen, et al.Clinical and Experimental Immunology|May 1, 1993
The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusionsA Gardulf, H Björvell, R Gustafson, et al.Clinical Immunology (Orlando, Fla.)|September 10, 2002
Express subcutaneous IgG infusions: decreased time of delivery with maintained safetyS Hansen, R Gustafson, C I E Smith, et al.Journal of Clinical Immunology|May 3, 2001
Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient womenA Gardulf, E Andersson, M Lindqvist, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 12, 2013
Health-related quality of life (HRQL) in immunodeficient adults with selective IgA deficiency compared with age- and gender-matched controls and identification of risk factors for poor HRQLG H Jörgensen, A Gardulf, M I Sigurdsson, et al.Journal of Clinical Immunology|February 8, 2013
Clinical symptoms in adults with selective IgA deficiency: a case-control studyG H Jorgensen, A Gardulf, M I Sigurdsson, et al.Journal of Advanced Nursing|May 1, 1995
Lifelong treatment with gammaglobulin for primary antibody deficiencies: the patients' experiences of subcutaneous self-infusions and home therapyA Gardulf, H Björvell, V Andersen, et al.Lancet (London, England)|February 11, 1995
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costsA Gardulf, V Andersen, J Björkander, et al.Pageof 264